Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

Z Chen, F Han, Y Du, H Shi, W Zhou - Signal transduction and targeted …, 2023 - nature.com
Having a hypoxic microenvironment is a common and salient feature of most solid tumors.
Hypoxia has a profound effect on the biological behavior and malignant phenotype of …

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Z Luo, M Tian, G Yang, Q Tan, Y Chen, G Li… - Signal transduction and …, 2022 - nature.com
Molecular oxygen (O2) is essential for most biological reactions in mammalian cells. When
the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is …

HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1

Z Yang, W Su, X Wei, S Qu, D Zhao, J Zhou, Y Wang… - Cell reports, 2023 - cell.com
Solid tumors have developed robust ferroptosis resistance. The mechanism underlying
ferroptosis resistance regulation in solid tumors, however, remains elusive. Here, we report …

[HTML][HTML] Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

CC Chen, W Tran, K Song, T Sugimoto, MB Obusan… - Cancer Cell, 2023 - cell.com
Trans-differentiation from an adenocarcinoma to a small cell neuroendocrine state is
associated with therapy resistance in multiple cancer types. To gain insight into the …

Clinical and biological features of neuroendocrine prostate cancer

Y Yamada, H Beltran - Current oncology reports, 2021 - Springer
Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …

The role of lineage plasticity in prostate cancer therapy resistance

H Beltran, A Hruszkewycz, HI Scher… - Clinical cancer …, 2019 - aacrjournals.org
Lineage plasticity has emerged as an important mechanism of treatment resistance in
prostate cancer. Treatment-refractory prostate cancers are increasingly associated with loss …

Molecular events in neuroendocrine prostate cancer development

Y Wang, Y Wang, X Ci, SYC Choi, F Crea, D Lin… - Nature Reviews …, 2021 - nature.com
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …